James Moe

James Moe is the Co-Founder, CEO and Head, Discovery & Strategy at OLIGOMERIX.

Moe has 20+ years industrial experience having held senior management positions in product development working on international teams in both early and late stage diagnostic, biotechnology and biopharmaceutical companies including Gene-Trak/Amoco Technology Ventures/Vysis, bioMerieux, and Mosaic Technologies. Prior to founding Oligomerix, he was Director of Product Development at Pyrosequencing, Senior Molecular Biologist at Spire Biomedical, and Director of Product Development at Q-RNA, Inc. Dr. Moe received his Ph.D. degree in Molecular Biology/Molecular Biophysics from Wesleyan University, did his postdoctoral studies at Vanderbilt University in the Center for Molecular Toxicology where he was jointly appointed in the Biochemistry Department in the Medical School, and the Chemistry Department in the College of Arts and Sciences, and has an MBA degree with a concentration in entrepreneurial studies from Boston University.

James Moe is the Co-Founder, CEO and Head, Discovery & Strategy at Oligomerix, based in New York, New York, United States, North America. With a background in Biotechnology, James Moe has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.